Sarcopenia in COPD: a systematic review and meta-analysis

E Benz, K Trajanoska, L Lahousse… - European respiratory …, 2019 - Eur Respiratory Soc
COPD is associated with a progressive loss of muscle mass and function. However, there is
an unmet need to define and standardise methods to estimate the prevalence of sarcopenia …

Initiating pharmacologic treatment in tobacco-dependent adults. An official American Thoracic Society clinical practice guideline

FT Leone, Y Zhang, S Evers-Casey… - American journal of …, 2020 - atsjournals.org
Background: Current tobacco treatment guidelines have established the efficacy of available
interventions, but they do not provide detailed guidance for common implementation …

Clinical significance of symptoms in smokers with preserved pulmonary function

PG Woodruff, RG Barr, E Bleecker… - … England Journal of …, 2016 - Mass Medical Soc
Background Currently, the diagnosis of chronic obstructive pulmonary disease (COPD)
requires a ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) …

Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets

LV Wain, N Shrine, MS Artigas, AM Erzurumluoglu… - Nature …, 2017 - nature.com
Chronic obstructive pulmonary disease (COPD) is characterized by reduced lung function
and is the third leading cause of death globally. Through genome-wide association …

[HTML][HTML] Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease

AJ Dicker, ML Crichton, EG Pumphrey… - Journal of Allergy and …, 2018 - Elsevier
Background Neutrophil extracellular traps (NETs) have been observed in the airway in
patients with chronic obstructive pulmonary disease (COPD), but their clinical and …

[HTML][HTML] Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic …

SMH Chan, S Selemidis, S Bozinovski… - Pharmacology & …, 2019 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a major incurable global health burden
and is currently the 4th largest cause of death in the world. Importantly, much of the disease …

COPD readmissions: addressing COPD in the era of value-based health care

T Shah, VG Press, M Huisingh-Scheetz, SR White - Chest, 2016 - Elsevier
Of those patients hospitalized for an exacerbation of COPD, one in five will require
rehospitalization within 30 days. Many developed countries are now implementing policies …

Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management

PG Woodruff, A Agusti, N Roche, D Singh, FJ Martinez - The Lancet, 2015 - thelancet.com
Chronic obstructive pulmonary disease (COPD) is a common, complex, and heterogeneous
disorder that is responsible for substantial and growing morbidity, mortality, and health-care …

Virtual reality rehabilitation in patients with chronic obstructive pulmonary disease: a randomized controlled trial

S Rutkowski, A Rutkowska, P Kiper… - … journal of chronic …, 2020 - Taylor & Francis
Purpose This study compared the effects of inpatient-based rehabilitation program of
patients with chronic obstructive pulmonary disease (COPD) using non-immersive virtual …

Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions

NA Hanania, DE O'Donnell - International journal of chronic …, 2019 - Taylor & Francis
Dyspnea is a distressing, debilitating, and near-ubiquitous symptom affecting patients with
COPD. In addition to the functional consequences of dyspnea, which include activity …